Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tadalafil
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Recipient : Eli Lilly
Deal Size : Undisclosed
Deal Type : Acquisition
Zuellig Pharma Acquires Cialis® and Alimta® from Lilly in ASEAN Markets
Details : Through the acquisition, Zuellig will access Cialis (tadalafil) for erectile dysfunction and Alimta (pemetrexed) for pleural mesothelioma and non-small cell lung cancer from Eli Lilly.
Brand Name : Cialis
Molecule Type : Small molecule
Upfront Cash : Undisclosed
February 06, 2024
Lead Product(s) : Tadalafil
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Recipient : Eli Lilly
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Quetiapine Hemifumarate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Recipient : Luye Pharma
Deal Size : Undisclosed
Deal Type : Agreement
Details : Luye grants Zuellig exclusive rights to distribute Seroquel (quetiapine fumarate, immediate release) and Seroquel XR (extended release formulation), atypical anti-psychotic medicines with antidepressant properties, for schizophrenia & bipolar disorder, i...
Brand Name : Seroquel
Molecule Type : Small molecule
Upfront Cash : Undisclosed
August 02, 2021
Lead Product(s) : Quetiapine Hemifumarate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Recipient : Luye Pharma
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : mRNA-1273
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Recipient : Moderna Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Zuellig Pharma Partners with Moderna to Supply Moderna’s Covid-19 Vaccine in Asia
Details : Zuellig Pharma’s division, ZP Therapeutics will supply, mRNA-1273, the COVID-19 Vaccine Moderna in Southeast Asia, Hong Kong, Macau and Taiwan.
Brand Name : mRNA-1273
Molecule Type : Vaccine
Upfront Cash : Undisclosed
April 29, 2021
Lead Product(s) : mRNA-1273
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Recipient : Moderna Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?